table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global PET Radiopharmaceuticals Market Size Analysis from 2022 to 2027
1.5.1 Global PET Radiopharmaceuticals Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global PET Radiopharmaceuticals Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global PET Radiopharmaceuticals Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: PET Radiopharmaceuticals Industry Impact
Chapter 2 Global PET Radiopharmaceuticals Competition by Types, Applications, and Top Regions and Countries
2.1 Global PET Radiopharmaceuticals (Volume and Value) by Type
2.1.1 Global PET Radiopharmaceuticals Consumption and Market Share by Type (2016-2021)
2.1.2 Global PET Radiopharmaceuticals Revenue and Market Share by Type (2016-2021)
2.2 Global PET Radiopharmaceuticals (Volume and Value) by Application
2.2.1 Global PET Radiopharmaceuticals Consumption and Market Share by Application (2016-2021)
2.2.2 Global PET Radiopharmaceuticals Revenue and Market Share by Application (2016-2021)
2.3 Global PET Radiopharmaceuticals (Volume and Value) by Regions
2.3.1 Global PET Radiopharmaceuticals Consumption and Market Share by Regions (2016-2021)
2.3.2 Global PET Radiopharmaceuticals Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global PET Radiopharmaceuticals Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global PET Radiopharmaceuticals Consumption by Regions (2016-2021)
4.2 North America PET Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia PET Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.4 Europe PET Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia PET Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia PET Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East PET Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.8 Africa PET Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania PET Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.10 South America PET Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America PET Radiopharmaceuticals Market Analysis
5.1 North America PET Radiopharmaceuticals Consumption and Value Analysis
5.1.1 North America PET Radiopharmaceuticals Market Under COVID-19
5.2 North America PET Radiopharmaceuticals Consumption Volume by Types
5.3 North America PET Radiopharmaceuticals Consumption Structure by Application
5.4 North America PET Radiopharmaceuticals Consumption by Top Countries
5.4.1 United States PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
5.4.2 Canada PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
5.4.3 Mexico PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 6 East Asia PET Radiopharmaceuticals Market Analysis
6.1 East Asia PET Radiopharmaceuticals Consumption and Value Analysis
6.1.1 East Asia PET Radiopharmaceuticals Market Under COVID-19
6.2 East Asia PET Radiopharmaceuticals Consumption Volume by Types
6.3 East Asia PET Radiopharmaceuticals Consumption Structure by Application
6.4 East Asia PET Radiopharmaceuticals Consumption by Top Countries
6.4.1 China PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
6.4.2 Japan PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
6.4.3 South Korea PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 7 Europe PET Radiopharmaceuticals Market Analysis
7.1 Europe PET Radiopharmaceuticals Consumption and Value Analysis
7.1.1 Europe PET Radiopharmaceuticals Market Under COVID-19
7.2 Europe PET Radiopharmaceuticals Consumption Volume by Types
7.3 Europe PET Radiopharmaceuticals Consumption Structure by Application
7.4 Europe PET Radiopharmaceuticals Consumption by Top Countries
7.4.1 Germany PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.2 UK PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.3 France PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.4 Italy PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.5 Russia PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.6 Spain PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.7 Netherlands PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.8 Switzerland PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.9 Poland PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 8 South Asia PET Radiopharmaceuticals Market Analysis
8.1 South Asia PET Radiopharmaceuticals Consumption and Value Analysis
8.1.1 South Asia PET Radiopharmaceuticals Market Under COVID-19
8.2 South Asia PET Radiopharmaceuticals Consumption Volume by Types
8.3 South Asia PET Radiopharmaceuticals Consumption Structure by Application
8.4 South Asia PET Radiopharmaceuticals Consumption by Top Countries
8.4.1 India PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
8.4.2 Pakistan PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
8.4.3 Bangladesh PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia PET Radiopharmaceuticals Market Analysis
9.1 Southeast Asia PET Radiopharmaceuticals Consumption and Value Analysis
9.1.1 Southeast Asia PET Radiopharmaceuticals Market Under COVID-19
9.2 Southeast Asia PET Radiopharmaceuticals Consumption Volume by Types
9.3 Southeast Asia PET Radiopharmaceuticals Consumption Structure by Application
9.4 Southeast Asia PET Radiopharmaceuticals Consumption by Top Countries
9.4.1 Indonesia PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
9.4.2 Thailand PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
9.4.3 Singapore PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
9.4.4 Malaysia PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
9.4.5 Philippines PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
9.4.6 Vietnam PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
9.4.7 Myanmar PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 10 Middle East PET Radiopharmaceuticals Market Analysis
10.1 Middle East PET Radiopharmaceuticals Consumption and Value Analysis
10.1.1 Middle East PET Radiopharmaceuticals Market Under COVID-19
10.2 Middle East PET Radiopharmaceuticals Consumption Volume by Types
10.3 Middle East PET Radiopharmaceuticals Consumption Structure by Application
10.4 Middle East PET Radiopharmaceuticals Consumption by Top Countries
10.4.1 Turkey PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.3 Iran PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.5 Israel PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.6 Iraq PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.7 Qatar PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.8 Kuwait PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.9 Oman PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 11 Africa PET Radiopharmaceuticals Market Analysis
11.1 Africa PET Radiopharmaceuticals Consumption and Value Analysis
11.1.1 Africa PET Radiopharmaceuticals Market Under COVID-19
11.2 Africa PET Radiopharmaceuticals Consumption Volume by Types
11.3 Africa PET Radiopharmaceuticals Consumption Structure by Application
11.4 Africa PET Radiopharmaceuticals Consumption by Top Countries
11.4.1 Nigeria PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
11.4.2 South Africa PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
11.4.3 Egypt PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
11.4.4 Algeria PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
11.4.5 Morocco PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 12 Oceania PET Radiopharmaceuticals Market Analysis
12.1 Oceania PET Radiopharmaceuticals Consumption and Value Analysis
12.2 Oceania PET Radiopharmaceuticals Consumption Volume by Types
12.3 Oceania PET Radiopharmaceuticals Consumption Structure by Application
12.4 Oceania PET Radiopharmaceuticals Consumption by Top Countries
12.4.1 Australia PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
12.4.2 New Zealand PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 13 South America PET Radiopharmaceuticals Market Analysis
13.1 South America PET Radiopharmaceuticals Consumption and Value Analysis
13.1.1 South America PET Radiopharmaceuticals Market Under COVID-19
13.2 South America PET Radiopharmaceuticals Consumption Volume by Types
13.3 South America PET Radiopharmaceuticals Consumption Structure by Application
13.4 South America PET Radiopharmaceuticals Consumption Volume by Major Countries
13.4.1 Brazil PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.2 Argentina PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.3 Columbia PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.4 Chile PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.5 Venezuela PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.6 Peru PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.8 Ecuador PET Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in PET Radiopharmaceuticals Business
14.1 Cardinal Health Inc. (U.S.)
14.1.1 Cardinal Health Inc. (U.S.) Company Profile
14.1.2 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Specification
14.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Mallinckrodt plc (Ireland)
14.2.1 Mallinckrodt plc (Ireland) Company Profile
14.2.2 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Specification
14.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 GE Healthcare (U.K.)
14.3.1 GE Healthcare (U.K.) Company Profile
14.3.2 GE Healthcare (U.K.) PET Radiopharmaceuticals Product Specification
14.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Lantheus Medical Imaging, Inc. (U.S.)
14.4.1 Lantheus Medical Imaging, Inc. (U.S.) Company Profile
14.4.2 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Specification
14.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Bayer AG (Germany)
14.5.1 Bayer AG (Germany) Company Profile
14.5.2 Bayer AG (Germany) PET Radiopharmaceuticals Product Specification
14.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Bracco Imaging S.p.A (Italy)
14.6.1 Bracco Imaging S.p.A (Italy) Company Profile
14.6.2 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Specification
14.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Eczacibasi-Monrol Nuclear Products (Turkey)
14.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Profile
14.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Specification
14.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Nordion, Inc. (Canada)
14.8.1 Nordion, Inc. (Canada) Company Profile
14.8.2 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Specification
14.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Advanced Accelerator Applications S.A. (France)
14.9.1 Advanced Accelerator Applications S.A. (France) Company Profile
14.9.2 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Specification
14.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 IBA Molecular Imaging (Belgium)
14.10.1 IBA Molecular Imaging (Belgium) Company Profile
14.10.2 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Specification
14.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global PET Radiopharmaceuticals Market Forecast (2022-2027)
15.1 Global PET Radiopharmaceuticals Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global PET Radiopharmaceuticals Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global PET Radiopharmaceuticals Value and Growth Rate Forecast (2022-2027)
15.2 Global PET Radiopharmaceuticals Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global PET Radiopharmaceuticals Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global PET Radiopharmaceuticals Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America PET Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia PET Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe PET Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia PET Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia PET Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East PET Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa PET Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania PET Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America PET Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global PET Radiopharmaceuticals Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global PET Radiopharmaceuticals Consumption Forecast by Type (2022-2027)
15.3.2 Global PET Radiopharmaceuticals Revenue Forecast by Type (2022-2027)
15.3.3 Global PET Radiopharmaceuticals Price Forecast by Type (2022-2027)
15.4 Global PET Radiopharmaceuticals Consumption Volume Forecast by Application (2022-2027)
15.5 PET Radiopharmaceuticals Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
